Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

US FDA warns against $30 DIY alternative to Mylan's EpiPen

The US FDA has warned people not to use a $30 DIY epinephrine delivery device developed after Mylan increased the price of the Epipen.

Colorcon and Dow extend controlled release alliance

Colorcon and Dow have expanded a nine year controlled release alliance to include further solubility, coating and ion exchange platforms.

Urine derived clot busters do not pose Zika risk says EMA

Clot busting drugs derived from human urine are no more likely to be contaminated with Zika virus than other medicines according to research by the EMA.

Sartorius pledges to cut development times with upstream suite

Sartorius Stedim Biotech claims it has a platform that can help biopharma companies carve months off the development time for new products.

Moderna to spend $110m on mRNA therapeutics manufacturing plant

Moderna Therapeutics has announced plans for a $110m (€98m) API manufacturing facility for its pipeline of mRNA therapeutics.

US FDA warns API firm Hebei Yuxing Bio-Engineering

Banned API firm Hebei Yuxing Bio-Engineering has had a microbial contamination problem at its plant since 2013 according to the US FDA.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...